Showing results (241-250 of 321) with videos related to
Sort By:
Pageof 33
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|December 1, 1980
Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechainsG E Adams, I Ahmed, E D Clarke, et al.Molecular Pharmaceutics|April 24, 2019
Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44Alice Spadea, Julio Manuel Rios de la Rosa, Annalisa Tirella, et al.The Journal of Pharmacy and Pharmacology|April 14, 2007
Design, synthesis and enzymatic evaluation of 6-bridged imidazolyluracil derivatives as inhibitors of human thymidine phosphorylaseVirginia A McNally, Mehdi Rajabi, Abdul Gbaj, et al.Journal of Medicinal Chemistry|July 1, 1991
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxinsM D Threadgill, P Webb, P O'Neill, et al.Oncology Research|January 1, 1997
Hypoxia response elementsJ F O'Rourke, G U Dachs, J M Gleadle, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2004
Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiationJoo-Young Kim, C M L West, H Valentine, et al.Anti-Cancer Drug Design|July 1, 1991
Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizersM A Naylor, M A Stephens, I J Stratford, et al.The American Surgeon|February 11, 2003
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delayRabih M Salloum, Mark P Saunders, Helena J Mauceri, et al.International Journal of Cancer|January 18, 2003
GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole bindingRachel E Airley, Juliette Loncaster, James A Raleigh, et al.Journal of Medicinal Chemistry|July 18, 1997
2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivoM A Naylor, M Jaffar, J Nolan, et al.Pageof 33